Drug Shortage Report for PULMICORT NEBUAMP 0.25 MG/ML
| Report ID | 178796 |
| Drug Identification Number | 01978918 |
| Brand name | PULMICORT NEBUAMP 0.25 MG/ML |
| Common or Proper name | budesonide |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.25MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20 ampoules |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-01-03 |
| Actual start date | |
| Estimated end date | 2023-01-31 |
| Actual end date | 2023-01-03 |
| Shortage status | Resolved |
| Updated date | 2023-01-04 |
| Company comments | Shortage avoided |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: [email protected]. Veuillez contacter le Service d'information médicale d'AstraZeneca Canada pour toute question spécifique au 1-800-668-6000 (EN) ou au 1-800-461-3787 (FR) ou par courriel : [email protected]. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-01-04 | French | Compare |
| v4 | 2023-01-04 | English | Compare |
| v3 | 2023-01-04 | English | Compare |
| v2 | 2022-12-16 | French | Compare |
| v1 | 2022-12-16 | English | Compare |
Showing 1 to 5 of 5